Advertisement
Screener

AKEBIA THERAPEUTICS, INC. (AKBA) Restructuring Reserve

2.8 / 5 stars · 68/120 Roast Me

AKEBIA THERAPEUTICS, INC. Restructuring Reserve

AKEBIA THERAPEUTICS, INC. (AKBA) had Restructuring Reserve of $1.01 million as of 2023-12-31, per its 10-K filed 2024-03-14.

Discontinued › Balance Sheet › Liabilities

us-gaap:RestructuringReserve · last filed 2024-03-14

  • 2023-12-31: Restructuring Reserve $1.01M.
  • 2022-12-31: Restructuring Reserve $3.76M.
  • 2022-09-30: Restructuring Reserve $4.24M.
  • 2022-06-30: Restructuring Reserve $6.92M.
Period endRestructuring Reserve
2023-12-31$1.01M
10-K · filed 2024-03-14
2022-12-31$3.76M
10-K · filed 2024-03-14
2022-09-30$4.24M
10-Q · filed 2022-11-03
2022-06-30$6.92M
10-Q · filed 2022-08-04
2021-12-31$0.00
10-K · filed 2024-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
MACROGENICS INC (MGNX)United States$0.242B-20.11
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33